يعرض 1 - 3 نتائج من 3 نتيجة بحث عن '"on behalf of the VERTIS-CV, Investigators"', وقت الاستعلام: 1.29s تنقيح النتائج
  1. 1
    دورية أكاديمية

    مصطلحات موضوعية: Nephrology, Endocrinology

    وصف الملف: text

    العلاقة: http://repo.dma.dp.ua/8351/1/clc.23665.pdfTest; http://repo.dma.dp.ua/8351/3/CJN.01130121SupplementaryData1.pdfTest; Cherney, David Z. I. and Dagogo-Jack, Samuel and McGuire, Darren K. and Cosentino, Francesco and Pratley, Richard and Shih, Weichung J. and Frederich, Robert and Maldonado, Mario and Liu, Jie and Wang, Shuai and Cannon, Christopher P. and on behalf of the VERTIS CV Investigators and Ukraine: and Koval, Olena and Khomazyuk, Tetyana and Panina, Svitlana (2021) Kidney outcomes using a sustained ≥40% decline in eGFR: A meta-analysis of SGLT2 inhibitor trials. Clinical Cardiology, 44 (8). pp. 1139-1143. ISSN 1932-8737 (Online)

  2. 2
    دورية أكاديمية

    مصطلحات موضوعية: Internal Medicine, Cardiology

    وصف الملف: text

    العلاقة: http://repo.dma.dp.ua/8350/1/CIRCULATIONAHA.120.051901%20%281%29.pdfTest; http://repo.dma.dp.ua/8350/3/CJN.01130121SupplementaryData1.pdfTest; Cherney, David Z.I. and McGuire, Darren K. and Charbonnel, Bernard and Cosentino, Francesco and Pratley, Richard and Dagogo-Jack, Samuel and Frederich, Robert and Maldonado, Mario and Liu, Jie and Pong, Annpey and Liu, Chih-Chin and Cannon, Christopher P. and On behalf of the VERTIS CV Investigators and Ukraine: and Koval, Olena and Khomazyuk, Tetyana and Panina, Svitlana (2021) Gradient of Risk and Associations With Cardiovascular Efficacy of Ertugliflozin by Measures of Kidney Function Observations From VERTIS CV. Circulation, 143. pp. 602-605. ISSN 0009-7322 (Print), 1524-4539 (Online)

  3. 3
    دورية أكاديمية

    مصطلحات موضوعية: Internal Medicine, Cardiology

    وصف الملف: text

    العلاقة: http://repo.dma.dp.ua/8365/1/Design_and_baseline_characteristics_of_the_eValuat.pdfTest; http://repo.dma.dp.ua/8365/3/nejmoa2004967_appendix.pdfTest; Cannon, Christopher P. and McGuire, Darren K. and Pratley, Richard and Dagogo-Jack, Sam and Mancuso, James and Huyck, Susan and Charbonnel, Bernard and Shih, Weichung J. and Gallo, Silvina and Masiukiewicz, Urszula and Golm, Gregory and Cosentino, Francesco and Lauring, Brett and Terra, Steven G. and on behalf of the VERTIS-CV, Investigators and Ukraine: and Godlevska, Olga and Chopey, Ivan and Teliatnikova, Zinaida and Kuskalo, Petro and Abrahamovych, Orest and Mankovskyi, Borys and Fushtey, Ivan and Myshanych, Galyna and Tykhonova, Susanna and Tseluyko, Vira and Koval, Olena and Parkhomenko, Oleksandr and Prokhorov, Oleksandr and Vayda, Myroslava and Martymianova, Larysa and Zharinova, Viktoriia and Prystupa, Lyudmyla and Pererva, Larysa and Kovalov, Oleksandr and Sokolova, Lyubov and Botsyurko, Volodymyr and Maslyanko, Vitaliy and Vlasenko, Maryna and Khomazyuk, Tetyana and Kulyk, Anna and Synenko, Volodymyr and Karpenko, Oleksandr and Mostovoy, Yuriy and Gyrina, Olga and Dolzhenko, Maryna and Donets, Oleksandra and Sorokina, Inna and Malynovsky, Yaroslav and Lysunets, Olena and Petrovskyy, Roman and Panina, Svitlana (2018) Design and baseline characteristics of the eValuation of ERTugliflozin effIcacy and Safety CardioVascular outcomes trial (VERTIS-CV). American Heart Journal, 206. pp. 11-23. ISSN 0002-8703 (Print), 1097-6744 (Online)